Epicardial adipose tissue thickness can be used to predict major adverse cardiac events
Citation
Tanindi, A., Erkan, A. F., & Ekici, B. (2015). Epicardial adipose tissue thickness can be used to predict major adverse cardiac events. Coronary Artery Disease, 26(8), 686–691. https://doi.org/10.1097/mca.0000000000000296Abstract
Objective Increase in epicardial adipose tissue (EAT)
thickness is associated with subclinical and manifest
coronary artery disease. In addition, it is associated with the
severity and extent of coronary atherosclerosis. We aimed to
investigate whether increased EAT thickness is associated
with adverse cardiovascular outcomes.
Patients and methods Two hundred consecutive patients
who were admitted with stable angina pectoris, unstable
angina pectoris or acute myocardial infarction (MI), and had
undergone coronary angiography were included and
followed for revascularization, nonfatal MI, hospitalization
for heart failure and cardiovascular death for 26 (5–30)
months.
Results There were significantly more revascularizations,
nonfatal MI and cardiovascular death in patients with an
initial EAT thickness more than 7mm (P<0.001 for all).
Significant predictors of cardiovascular death were
identified as an EAT thickness more than 7mm [hazard ratio
(HR) 1.9, 95% confidence interval (CI) 0.4–8.3, P=0.039]
and diabetes (HR 3.42, 95% CI 0.7–17.5, P=0.014) in the
multivariate Cox regression analysis. Event-free survival for
cardiovascular death in the EAT up to 7mm group was
97.9%, whereas it was 90.7% in the EAT more than 7mm
group (P=0.021). In addition, significant predictors of MI
were identified as an EAT thickness more than 7mm (HR
2.4, 95% CI 0.6–10.0, P=0.021) and diabetes (HR 3.4, 95%
CI 1.0–11.2, P=0.04). Event-free survival for MI in the EAT up
to 7mm group was 96.4%, whereas it was 68.2% in the EAT
more than 7mm group (P=0.001).
Conclusion Increase in EAT thickness independently
predicts adverse cardiac events including MI and
cardiovascular death. Coron Artery Dis 26:686–691
Copyright © 2015 Wolters Kluwer Health, Inc. All rights
reserved